Quarterly report pursuant to Section 13 or 15(d)

Concentrations

v2.4.0.8
Concentrations
 9 Months Ended
Sep. 30, 2014
Risks And Uncertainties [Abstract]  
Concentrations

NOTE 11—CONCENTRATIONS

Revenue from the Company’s products for the three and nine months ended September 30, 2014 and 2013 are as follows:

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2014

 

 

2013

 

 

2014

 

 

2013

 

Laser systems

 

57.9

%

 

 

65.8

%

 

 

60.2

%

 

 

67.9

%

Imaging systems

 

11.0

%

 

 

7.8

%

 

 

9.5

%

 

 

8.1

%

Consumables and other

 

12.6

%

 

 

13.2

%

 

 

13.6

%

 

 

11.9

%

Services

 

18.2

%

 

 

12.9

%

 

 

16.3

%

 

 

11.7

%

License fees and royalties

 

0.3

%

 

 

0.3

%

 

 

0.4

%

 

 

0.4

%

Total revenue

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

No individual customer represented more than 10% of the Company’s revenue for the three and nine months ended September 30, 2014 and 2013.

The Company maintains its cash and cash equivalent accounts with established commercial banks. Such cash deposits periodically exceed the Federal Deposit Insurance Corporation insured limit.

No individual customer represented more than 10% of the Company’s accounts receivable at September 30, 2014 and December 31, 2013.

The Company currently purchases certain key components of its products from single suppliers. Although there are a limited number of manufacturers of these key components, management believes that other suppliers could provide similar key components on comparable terms. A change in suppliers, however, could cause delays in manufacturing and a possible loss of sales, which could adversely affect the Company’s results of operations.